Efficacy & Safety Study of Relugolix in Women With Heavy Menstrual Bleeding Associated With Uterine Fibroids

NCT06671548 · clinicaltrials.gov ↗

PHASE3

Phase

RECRUITING

Status

120

Enrollment

INDUSTRY

Sponsor class

Conditions

Heavy Menstrual Bleeding
Uterine Fibroids

Interventions

DRUG: Relugolix
DRUG: Relugolix placebo

Sponsor

Qilu Pharmaceutical Co., Ltd.